drugset / Trial / NCT01585259
Anfibatide Phase Ib-IIa Clinical Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
Investigate the safety and efficacy of Anfibatide in non-ST segment myocardial infarction patients
Timeline
- Start
- 2012-07
- Primary completion
- 2014-12
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Anfibatide | Protein / enzyme biologic | 2 iu | Intravenous |
| Comparator | Anfibatide | Protein / enzyme biologic | 3 iu | Intravenous |
| Comparator | Anfibatide | Protein / enzyme biologic | 5 iu | Intravenous |